Answers are grounded in this paper and cite their sources.
The present analysis suggests that gender interacts with efficacy of initial irinotecan when used in combination with fluoropyrimidines and bevacizumab. Although male patients derived a significant and clinically meaningful benefit from initial combination chemotherapy, this was not observed in female patients.
No takes yet. Share an insight, caveat, or question.
Heinrich et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: